{'52WeekChange': -0.4236055,
 'SandP52WeekChange': 0.0644362,
 'address1': '10 North High Street',
 'address2': 'Suite 200',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 7.18,
 'askSize': 1000,
 'averageDailyVolume10Day': 166987,
 'averageVolume': 95407,
 'averageVolume10days': 166987,
 'beta': 2.37231,
 'beta3Year': None,
 'bid': 7.25,
 'bidSize': 1300,
 'bookValue': 2.193,
 'category': None,
 'circulatingSupply': None,
 'city': 'West Chester',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 7.263,
 'dayLow': 6.82,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -4.088,
 'enterpriseToRevenue': None,
 'enterpriseValue': 130265336,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 10.865714,
 'fiftyTwoWeekHigh': 18.67,
 'fiftyTwoWeekLow': 6.79,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 8292648,
 'forwardEps': -1.97,
 'forwardPE': -3.6192894,
 'fromCurrency': None,
 'fullTimeEmployees': 17,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.48924,
 'heldPercentInstitutions': 0.35627,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/verrica.com',
 'longBusinessSummary': 'Verrica Pharmaceuticals Inc., a clinical stage '
                        'medical dermatology company, develops and '
                        'commercializes dermatological treatments in the '
                        "United States. The company's lead product candidate "
                        'include VP-102 that is in phase III clinical trial '
                        'for the treatment of molluscum contagiosum; in phase '
                        'II clinical trial for the treatment of common warts; '
                        'and completed phase I clinical trial for the '
                        'treatment of Genital warts. It is also developing '
                        'cantharidin-based product candidate, VP-103 for the '
                        'treatment of plantar warts. The company was founded '
                        'in 2013 and is headquartered in West Chester, '
                        'Pennsylvania.',
 'longName': 'Verrica Pharmaceuticals Inc.',
 'market': 'us_market',
 'marketCap': 184057392,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_319720251',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -30550000,
 'nextFiscalYearEnd': 1640908800,
 'open': 7.07,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': 0.05,
 'phone': '484-453-3300',
 'previousClose': 7.06,
 'priceHint': 2,
 'priceToBook': 3.2512538,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 7.263,
 'regularMarketDayLow': 6.82,
 'regularMarketOpen': 7.07,
 'regularMarketPreviousClose': 7.06,
 'regularMarketPrice': 7.07,
 'regularMarketVolume': 130517,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 25775200,
 'sharesPercentSharesOut': 0.0322,
 'sharesShort': 830366,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 492697,
 'shortName': 'Verrica Pharmaceuticals Inc.',
 'shortPercentOfFloat': 0.0674,
 'shortRatio': 9.75,
 'startDate': None,
 'state': 'PA',
 'strikePrice': None,
 'symbol': 'VRCA',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -1.226,
 'twoHundredDayAverage': 11.841079,
 'volume': 130517,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.verrica.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '19380'}